Publications (230) PABLO ROJO CONEJO publications

filter_list

2025

  1. Abstracts of the 26th International Workshop on Clinical Pharmacology of HIV, Hepatitis and other Antiviral Drugs 2025, 3-4 September 2025, Amsterdam, the Netherlands

    British journal of clinical pharmacology, Vol. 91, pp. 12-13

  2. Adolescents in phase 3 HIV clinical trials

    The Lancet Child and Adolescent Health

  3. Are children and adolescents living with HIV in Europe and South Africa at higher risk of SARS-CoV-2 and poor COVID-19 outcomes?

    Epidemiology and Infection, Vol. 153

  4. Correction to: Sustained aviremia despite anti-retroviral therapy non-adherence in male children after in utero HIV transmission (Nature Medicine, (2024), 30, 10, (2796-2804), 10.1038/s41591-024-03105-4)

    Nature Medicine

  5. DNA methylation signatures of severe RSV infection in infants: evidence from non-invasive saliva samples

    Epigenetics and Chromatin , Vol. 18, Núm. 1

  6. Immunity to Streptococcus pyogenes and Common Respiratory Viruses at Age 0 to 4 Years after COVID-19 Restrictions

    JAMA Network Open, Vol. 8, Núm. 10

  7. Palliative care training in Spanish medical schools: student assessment

    BMJ Supportive and Palliative Care

  8. Prognostic Factors of Late-onset Hearing Loss in Infants With Congenital Cytomegalovirus and Normal Audiologic Assessment at Birth

    Pediatric Infectious Disease Journal

  9. Statistical analysis plan for the “empirical treatment against cytomegalovirus and tuberculosis in HIV-infected infants with severe pneumonia” clinical trial

    Trials, Vol. 26, Núm. 1

  10. Virological outcomes and genotypic resistance on dolutegravir-based antiretroviral therapy versus standard of care in children and adolescents: a secondary analysis of the ODYSSEY trial

    The Lancet HIV, Vol. 12, Núm. 3, pp. e201-e213

2024

  1. Afrontando la muerte: reuniones de duelo para profesionales en el cuidado pediátrico

    Anales de Pediatría: Publicación Oficial de la Asociación Española de Pediatría ( AEP ), Vol. 101, Núm. 5, pp. 351-352

  2. Analytical treatment interruption in children living with HIV: position statement from the EPIICAL consortium

    The Lancet HIV, Vol. 11, Núm. 10, pp. e700-e710

  3. Antiviral Treatment and Risk of Hearing Loss in Asymptomatic and Mild Symptomatic Infants With Congenital Cytomegalovirus

    Pediatric Infectious Disease Journal

  4. Early inflammation as a footprint of increased mortality risk in infants living with HIV from three African countries

    Scientific Reports, Vol. 14, Núm. 1

  5. Effectiveness and Safety of Direct-acting Antivirals for Treatment of Adolescents With HCV/HIV Coinfection: Real-world Data From Europe

    Pediatric Infectious Disease Journal, Vol. 43, Núm. 5, pp. E155-E159

  6. High mortality following early initiation of antiretroviral therapy in infants living with HIV from three African countries

    eClinicalMedicine, Vol. 73

  7. Host gene expression signatures to identify infection type and organ dysfunction in children evaluated for sepsis: a multicentre cohort study

    The Lancet Child and Adolescent Health, Vol. 8, Núm. 5, pp. 325-338

  8. Infective endocarditis in pediatric patients: a decade of insights from a leading Spanish heart surgery reference center

    European Journal of Pediatrics, Vol. 183, Núm. 9, pp. 3905-3913

  9. Low unspliced cell-associated HIV RNA in early treated adolescents living with HIV on long suppressive ART

    Frontiers in Immunology, Vol. 15

  10. Penta Network: State-of-the-Art Research in Pediatric Human Immunodeficiency Virus

    Clinics in Perinatology, Vol. 51, Núm. 4, pp. 925-933